Generic Plavix (clopidogrel) may not be here to stay
Generic Plavix (clopidogrel) may not be here to stay.
Apotex is challenging a patent that's not due to expire until 2011. They think they have a good case, so they launched a generic BEFORE the case was resolved.
A few days later, Bristol-Myers and Sanofi got an injunction to stop sales of the generic until a final ruling is made.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote